RxSight, Inc.

• RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
  The Manila Times · 24 Oct 2026
• RxSight Inc. Q3FY26 Results: Earnings call set for November 3, 2026
  scanx.trade · 20 Oct 2026
• RxSight Appoints Two Eyecare Industry Leaders to Drive Commercial Transformation
  VisionMonday.com · 20 Oct 2026
• RxSight Appoints Taryn Conway as Chief Commercial Officer, Frank Shields as EVP of Sales and Commercial Strategy
  citybiz · 19 Oct 2026
• RxSight, Inc. Announces Executive Appointments
  www.marketscreener.com · 19 Oct 2026
• A sales leader with over 30 years in eye care joins RxSight.
  Stock Titan · 19 Oct 2026
• Latham & Watkins Advises RxSight on Collaboration With Alcon to Develop Adjustable PCIOLsLatham & Watkins Advises RxSight on Collaboration With Alcon to Develop Adjustable PCIOLs
  Legal Desire · 19 Oct 2026
• RxSight announces Alcon lens deal as analysts target RxSight stock at USD 8.17
  AD HOC NEWS · 16 Oct 2026
• Latham & Watkins Advises RxSight on Collaboration With Alcon to Develop Adjustable PCIOLs
  Latham & Watkins LLP · 15 Oct 2026
• RxSight Inc. (RXST) Ticks Higher: Shares Gain 2.14% to Close at $4.77 - Dealer Delta
  https://www.siam.in/ · 30 Sep 2026
• RxSight Inc. (RXST) Ticks Higher: Shares Gain 2.14% to Close at $4.77 - SuperTrend
  www.dars.gov.et · 30 Sep 2026
• RxSight Realigns Top Management
  Medical Product Outsourcing · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →